Team:HZAU-China/Human practice=4

From 2013.igem.org

(Difference between revisions)
m
 
(13 intermediate revisions not shown)
Line 37: Line 37:
ul.menu:after{content:"";display:block;height:0;clear:both;visibility:hidden;}
ul.menu:after{content:"";display:block;height:0;clear:both;visibility:hidden;}
ul.menu,
ul.menu,
-
ul.menu ul {padding:0;margin:0;list-style:none;position:;width:220px;background:#ddd;font-family:arial, sans-serif;}
+
ul.menu ul {padding:0;margin:0;list-style:none;position:;width:220px;background:#d3f18c;font-family:arial, sans-serif;}
ul.menu {z-index:100;padding:10px;margin:0 auto;}
ul.menu {z-index:100;padding:10px;margin:0 auto;}
ul.menu ul {z-index:50;
ul.menu ul {z-index:50;
Line 49: Line 49:
ul.menu > li {margin-top:2px;font-size:12px;}
ul.menu > li {margin-top:2px;font-size:12px;}
ul.menu > li a {font:normal 16px/29px arial, sans-serif;color:#fff;text-decoration:none;}
ul.menu > li a {font:normal 16px/29px arial, sans-serif;color:#fff;text-decoration:none;}
-
ul.menu label.open {display:block;background:#c00 no-repeat 170px 12px;line-height:30px;position:relative;z-
+
ul.menu label.open {display:block;background:#517b1f no-repeat 170px 12px;line-height:30px;position:relative;z-
-
 
+
index:100;font:normal 12px/30px arial, sans-serif;color:#fff;border-radius:10px 10px 0 0;}
index:100;font:normal 12px/30px arial, sans-serif;color:#fff;border-radius:10px 10px 0 0;}
-
ul.menu label.open b {color:#ff0;}
+
ul.menu span {display:block;background:#517b1f;line-height:30px;position:relative;z-index:100;font-size: 16px;padding-left:10px;}
-
ul.menu span {display:block;background:#c00;line-height:30px;position:relative;z-index:100;font-size: 16px;padding-left:10px;}
+
ul.menu label img {position:absolute;left:0;top:0;width:100%;height:30px;}
ul.menu label img {position:absolute;left:0;top:0;width:100%;height:30px;}
ul.menu ul li {margin-top:-30px;
ul.menu ul li {margin-top:-30px;
Line 62: Line 60:
transition: 0.5s;
transition: 0.5s;
}
}
-
ul.menu ul li a {display:block;font:normal 16px/29px arial, sans-serif;color:#000;background:#ccc;}
+
ul.menu ul li a {display:block;font:normal 16px/29px arial, sans-serif;color:#000;background:#b3e24b;}
-
ul.menu ul li a:hover {background:#ddd;}
+
ul.menu ul li a:hover {background:#d3f18c;}
ul.menu input {position:absolute;left:-9999px;}
ul.menu input {position:absolute;left:-9999px;}
ul.menu li input:checked + label {background:#069;}
ul.menu li input:checked + label {background:#069;}
-
ul.menu li input:checked ~ ul {background:#ccc;padding-bottom:10px;}
+
ul.menu li input:checked ~ ul {background:#b3e24b;padding-bottom:10px;}
ul.menu li input:checked ~ ul li {margin-top:0;}
ul.menu li input:checked ~ ul li {margin-top:0;}
ul.menu label.close {display:block;width:200px;height:30px;background:transparent url("/jscss/demoimg/201208/u-arrow.gif")  
ul.menu label.close {display:block;width:200px;height:30px;background:transparent url("/jscss/demoimg/201208/u-arrow.gif")  
Line 76: Line 74:
ul.menu input.close:checked ~ ul li {margin-top:-30px;}
ul.menu input.close:checked ~ ul li {margin-top:-30px;}
</style>
</style>
 +
<script>
<script>
Line 97: Line 96:
     <ul class="menu">
     <ul class="menu">
         <li><a href="https://2013.igem.org/Team:HZAU-China/Human_practice=1"><span>Meeting with WHU and HUST</span></a></li>
         <li><a href="https://2013.igem.org/Team:HZAU-China/Human_practice=1"><span>Meeting with WHU and HUST</span></a></li>
-
         <li><a href="https://2013.igem.org/Team:HZAU-China/Human_practice=2"><span>Visit To Keqian Biotech Company</span></a></li>
+
        <li><a href="https://2013.igem.org/Team:HZAU-China/Collaboration"><span>Collaboration</span></a></li>
-
         <li><a href="https://2013.igem.org/Team:HZAU-China/Human_practice=3"><span>To make IGEM and Synthetic Biology Universal</span></a></li>
+
         <li><a href="https://2013.igem.org/Team:HZAU-China/Human_practice=2"><span>Visiting Keqian Biotech Company</span></a></li>
-
         <li><a href="https://2013.igem.org/Team:HZAU-China/Human_practice=4"><span style="font-size:20px;color=#fff;">Understanding the Safety assessment of GM rice</span></a></li>         
+
         <li><a href="https://2013.igem.org/Team:HZAU-China/Human_practice=3"><span>Making IGEM and Synthetic Biology Popular</span></a></li>
 +
         <li><a href="https://2013.igem.org/Team:HZAU-China/Human_practice=4"><span style="font-size:20px;color=#fff;">Understanding the Safety Assessment of GM rice</span></a></li>
 +
        <li><a href="https://static.igem.org/mediawiki/2013/1/11/IGEM%E7%89%B9%E5%88%8A.pdf"><span>Publication</span></a></li>         
     </body>
     </body>
   </div>
   </div>
Line 109: Line 110:
       <p><br></p>
       <p><br></p>
-
<p  style="text-align:center;"><a><img width="710" src="https://static.igem.org/mediawiki/2013/a/a6/%E9%99%88%E6%B5%A9.jpg" ></a></br></p>
+
<p  style="text-align:center;"><a><img height="450" src="https://static.igem.org/mediawiki/2013/a/a6/%E9%99%88%E6%B5%A9.jpg" ></a></br></p>
-
<p style="font-size:16px;font-family:arial, sans-serif;">In order to find ideas for our first ethical assessment, In June 20th, 2013, we interviewed of Dr. Chen Hao in National Key Laboratory of Crop Genetic Improvement. of HZAU.</p>
+
<p style="font-size:16px;font-family:arial, sans-serif;">In order to find ideas for our first ethical assessment, In June 20th, 2013, we interviewed of Dr. Chen Hao in National Key Laboratory of Crop Genetic Improvement of HZAU.</p>
-
<p style="font-size:16px;font-family:arial, sans-serif;">In the conference room, we briefly introduced the content of our team IGEM project again .Chen began to show us the safety assessment of genetically modified rice. It involved applying to the Ministry of Agriculture project, a detailed safety assessment pilot Conditions and the production after the security risk estimates. When he asked our team if we were familiar with the rabies G protein as well as the level of security about fleas, we felt sorry and knew that the safety assessment had had been a real pressure, we did not even know what a risk assessment rating. To address this issue, Chen made several suggestions to us. First, to better understand the safety assessment rules, at home and abroad should be covered. Second, set up a team of your own safety assessment methods, so that other people can have a more clear understanding on our evaluation criteria. Finally, if we wanted put into production, you must go to the relevant enterprises to multi-site visits and inquiries.</p>
+
<p style="font-size:16px;font-family:arial, sans-serif;">In the conference room, we briefly introduced the content of our project again. Mr.Chen began to show us the safety assessment of genetically modified rice. It involved applying to the Ministry of Agriculture project, a detailed safety assessment pilot Conditions and the production after the security risk estimates. When he asked us if we were familiar with the rabies G protein as well as the level of security about fleas, we felt sorry and knew that the safety assessment had had been a real pressure, we did not even know what a risk assessment rating. To address this issue, Chen made several suggestions to us. First, to better understand the safety assessment rules, at home and abroad should be covered. Second, set up a team of your own safety assessment methods, so that other people can have a more clear understanding on our evaluation criteria. Finally, if we wanted put into production, you must go to the relevant enterprises to multi-site visits and inquiries.</p>
<p style="font-size:16px;font-family:arial, sans-serif;">In the interview, Chen made our deepest hopes and wishes. Through this meeting, we learned the preliminary knowledge of safety assessment .In the following days , there wiould be great progress.</p>
<p style="font-size:16px;font-family:arial, sans-serif;">In the interview, Chen made our deepest hopes and wishes. Through this meeting, we learned the preliminary knowledge of safety assessment .In the following days , there wiould be great progress.</p>

Latest revision as of 02:14, 28 September 2013


The report for interviewing Doctor Chen



In order to find ideas for our first ethical assessment, In June 20th, 2013, we interviewed of Dr. Chen Hao in National Key Laboratory of Crop Genetic Improvement of HZAU.

In the conference room, we briefly introduced the content of our project again. Mr.Chen began to show us the safety assessment of genetically modified rice. It involved applying to the Ministry of Agriculture project, a detailed safety assessment pilot Conditions and the production after the security risk estimates. When he asked us if we were familiar with the rabies G protein as well as the level of security about fleas, we felt sorry and knew that the safety assessment had had been a real pressure, we did not even know what a risk assessment rating. To address this issue, Chen made several suggestions to us. First, to better understand the safety assessment rules, at home and abroad should be covered. Second, set up a team of your own safety assessment methods, so that other people can have a more clear understanding on our evaluation criteria. Finally, if we wanted put into production, you must go to the relevant enterprises to multi-site visits and inquiries.

In the interview, Chen made our deepest hopes and wishes. Through this meeting, we learned the preliminary knowledge of safety assessment .In the following days , there wiould be great progress.